A detailed history of Castleview Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Castleview Partners, LLC holds 510 shares of MDT stock, worth $43,967. This represents 0.03% of its overall portfolio holdings.

Number of Shares
510
Previous 647 21.17%
Holding current value
$43,967
Previous $58,000 22.41%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$76.84 - $91.03 $10,527 - $12,471
-137 Reduced 21.17%
510 $45,000
Q2 2024

Jul 31, 2024

BUY
$78.71 - $87.02 $1,416 - $1,566
18 Added 2.86%
647 $50,000
Q1 2024

May 09, 2024

SELL
$82.84 - $88.09 $9,278 - $9,866
-112 Reduced 15.11%
629 $54,000
Q4 2023

Feb 05, 2024

BUY
$69.43 - $83.43 $12,080 - $14,516
174 Added 30.69%
741 $61,000
Q3 2023

Oct 26, 2023

SELL
$78.22 - $90.4 $17,521 - $20,249
-224 Reduced 28.32%
567 $44,000
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $1,271 - $1,462
-16 Reduced 1.98%
791 $69,000
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $4,526 - $5,167
59 Added 7.89%
807 $65,000
Q4 2022

Feb 01, 2023

BUY
$76.18 - $87.74 $6,018 - $6,931
79 Added 11.81%
748 $58,000
Q3 2022

Nov 10, 2022

SELL
$80.75 - $95.31 $77,035 - $90,925
-954 Reduced 58.78%
669 $54,000
Q2 2022

Aug 17, 2022

SELL
$87.4 - $113.09 $12.6 Million - $16.3 Million
-144,041 Reduced 98.89%
1,623 $145,000
Q2 2022

Aug 16, 2022

BUY
$87.4 - $113.09 $12.7 Million - $16.5 Million
145,664 New
145,664 $13.1 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $45.5 Million - $50.9 Million
-452,593 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$99.53 - $127.75 $44.8 Million - $57.5 Million
450,340 Added 19988.46%
452,593 $46.8 Million
Q2 2021

Aug 17, 2021

BUY
$118.19 - $131.5 $266,282 - $296,269
2,253 New
2,253 $280,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.